AJR Am J Roentgenol
- OUEIDAT K, Baird GL, Barclay-White B, Kozlowski K, et al
Cryoablation of Primary Breast Cancer in Patients Ineligible for Clinical Trials:
A Multiinstitutional Study.
AJR Am J Roentgenol. 2024 Jul 10. doi: 10.2214/AJR.24.31392.
Ann Oncol
- FREEDMAN RA, Heiling HM, Li T, Trapani D, et al
Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated
HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer
Research Consortium Trial 022.
Ann Oncol. 2024 Jul 6:S0923-7534(24)01015-9. doi: 10.1016/j.annonc.2024.
- ROWLANDS CF, Allen S, Balmana J, Domchek SM, et al
Population-based germline breast cancer gene association studies and
meta-analysis to inform wider mainstream testing.
Ann Oncol. 2024 Jul 8:S0923-7534(24)01014-7. doi: 10.1016/j.annonc.2024.
Ann Surg Oncol
- WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast
Reconstructions: Feasibility and Clinical Outcomes.
Ann Surg Oncol. 2024;31:5409-5416.
- SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples
Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5148-5156.
- HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
"Peace of Mind" After Mastectomy: A Scoping Review.
Ann Surg Oncol. 2024;31:5168-5179.
- BEST CS, Kung TA
ASO Author Reflections: Improving Patient Access to Autologous Breast
Reconstruction.
Ann Surg Oncol. 2024;31:5417-5418.
- WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
ASO Visual Abstract: Simultaneous Co-surgeon Deep Inferior Epigastric Perforator
(DIEP) Flap Breast Reconstructions-Feasibility and Clinical Outcomes.
Ann Surg Oncol. 2024;31:5419-5420.
- HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
ASO Visual Abstract: "Peace of Mind" After Mastectomy: A Scoping Review.
Ann Surg Oncol. 2024;31:5213-5214.
- SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
ASO Visual Abstract: Positive Nipple Margins in Nipple Sparing
Mastectomy-Management of Nipples Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5230.
- DALY AE, Anderman KJ, Smith BL
ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy:
Management of Nipples Containing Cancer or Atypia.
Ann Surg Oncol. 2024;31:5211-5212.
- FALADE I, Switalla K, Quirarte A, Baxter M, et al
ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared
to Standard Breast Conserving Surgery for Patients with Invasive Lobular
Carcinoma.
Ann Surg Oncol. 2024;31:5004-5005.
- DI LENA E, Iny E, Wong SM, Bassel M, et al
Impact of Margin Status on Local Recurrence in Patients with Breast Cancer
Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A
Retrospective Multi-Institutional Cohort Study.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15716.
- CHEUN JH, Chung S, Han JH, Lee YW, et al
Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent
Contemporary Management: A Report from the Korean Breast Cancer Society Survivor
Research Group.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
- BOTTY VAN DEN BRUELE A, Weiss A
Updated Guidelines on When to Consider Germline Testing for Patients with Breast
Cancer.
Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15638.
- NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
Demographics and Clinical Decision Making in Patients with Germline Moderate
Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15793.
- DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent
Pregnancies.
Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15798.
- CARROLL JF, Hoskin TL, Hieken TJ
Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant
Immunotherapy for Node-Positive Breast Cancer.
Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15826.
- BELLINI A, Sauder CAM
ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast
Cancer Survivors.
Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15803.
- SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast
Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the
ISPY-2 Clinical Trial.
Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15792.
BMC Cancer
- POMEY MP, Iliescu Nelea M, Vialaron C, Normandin L, et al
The black box of the relationship between breast cancer patients and accompanying
patients: the accompanied patients' point of view.
BMC Cancer. 2024;24:822.
BMJ
- RIMMER A
Navigating breastfeeding through cancer treatment.
BMJ. 2024;386:q1284.
Br J Cancer
- BESSE A, Sedlarikova L, Buechler L, Kraus M, et al
HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative
breast cancer.
Br J Cancer. 2024 Jul 5. doi: 10.1038/s41416-024-02774.
Breast Cancer
- WEI JF, Li F, Lin JW, Dou ZA, et al
Development and validation of a neoadjuvant chemotherapy pathological complete
remission model based on Reg IV expression in breast cancer tissues: a clinical
retrospective study.
Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01609.
- LUO Y, Chen X, Lv R, Li Q, et al
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage
breast cancer: a propensity score matching analysis.
Breast Cancer. 2024 Jul 8. doi: 10.1007/s12282-024-01611.
- PINELLI F, Barbani F, Defilippo B, Fundaro A, et al
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy:
comparison between PICC and PICC-port.
Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01608.
- NAKAMOTO S, Iwamoto T, Taira N, Kajiwara Y, et al
The effect of exercise and educational programs for breast cancer patients on the
development of breast cancer-related lymphoedema: secondary endpoint from a
randomized controlled trial in the Setouchi Breast Project-10.
Breast Cancer. 2024 Jul 9. doi: 10.1007/s12282-024-01610.
Breast Cancer (Dove Med Press)
- BUYUKBAYRAM ME, Hannarici Z, Duzkopru Y, Turhan A, et al
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic
Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker.
Breast Cancer (Dove Med Press). 2024;16:329-339.
Breast Cancer Res
- KADER T, Provenzano E, Jayawardana MW, Hendry S, et al
Stromal lymphocytes are associated with upgrade of B3 breast lesions.
Breast Cancer Res. 2024;26:115.
Breast Cancer Res Treat
- THOMPSON CN, Chandler J, Ju T, Tsai J, et al
Residual cancer burden in two-stage nipple sparing mastectomy after first stage
lumpectomy and devascularization of the nipple areolar complex.
Breast Cancer Res Treat. 2024;207:143-149.
- PAN K, Nelson RA, Chlebowski RT, Piela R, et al
Ductal carcinoma in situ and cause-specific mortality among younger and older
postmenopausal women: the Women's Health Initiative.
Breast Cancer Res Treat. 2024;207:65-79.
- ZENG A, Houssami N, Noguchi N, Nickel B, et al
Frequency and characteristics of errors by artificial intelligence (AI) in
reading screening mammography: a systematic review.
Breast Cancer Res Treat. 2024;207:1-13.
- ANDERSON SA, Bartow BB, Harada S, Siegal GP, et al
p53 protein expression patterns associated with TP53 mutations in breast
carcinoma.
Breast Cancer Res Treat. 2024;207:213-222.
- SIMMONS R, Kameyama H, Kubota S, Sun Y, et al
Sustained delivery of celecoxib from nanoparticles embedded in hydrogel injected
into the biopsy cavity to prevent biopsy-induced breast cancer metastasis.
Breast Cancer Res Treat. 2024 Jul 5. doi: 10.1007/s10549-024-07410.
- CHEN HW, Kuo WH, Lu YS, Chen IC, et al
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in
breast cancer risk among East Asian women.
Breast Cancer Res Treat. 2024 Jul 5. doi: 10.1007/s10549-024-07418.
- BRANTLEY KD, Tamimi RM
The association between infectious agents and breast cancer: a review of the
epidemiologic evidence.
Breast Cancer Res Treat. 2024 Jul 6. doi: 10.1007/s10549-024-07388.
- CHIDA K, Oshi M, Roy AM, Sato T, et al
Enhanced cancer cell proliferation and aggressive phenotype counterbalance in
breast cancer with high BRCA1 gene expression.
Breast Cancer Res Treat. 2024 Jul 7. doi: 10.1007/s10549-024-07421.
- SANJAYA A, Ratnawati H, Adhika OA, Rahmatilah FR, et al
The heterogeneity of breast cancer metastasis: a bioinformatics analysis
utilizing single-cell RNA sequencing data.
Breast Cancer Res Treat. 2024 Jul 11. doi: 10.1007/s10549-024-07428.
- DU KY, Wu S, Ma X, Liu Y, et al
Circulating tumor cell phenotype detection based on epithelial-mesenchymal
transition markers combined with clinicopathological risk has potential to better
predict recurrence in stage III breast cancer treated with neoadjuvant
chemotherapy: a pilot s
Breast Cancer Res Treat. 2024 Jul 11. doi: 10.1007/s10549-024-07430.
- KUMAR S, Ziegler Y, Plotner BN, Flatt KM, et al
Resistance to FOXM1 inhibitors in breast cancer is accompanied by impeding
ferroptosis and apoptotic cell death.
Breast Cancer Res Treat. 2024 Jul 9. doi: 10.1007/s10549-024-07420.
- LIANG E, Beshara M, Sheng H, Huang XW, et al
A prospective study of vitamin D, proinflammatory cytokines, and risk of
fragility fractures in women on aromatase inhibitors for breast cancer.
Breast Cancer Res Treat. 2024 Jul 8. doi: 10.1007/s10549-024-07423.
Cancer
- ELGHAZALY H, Azim HA, Rugo HS, Cameron D, et al
Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a
personalized approach"-The Breast-Gynecological and Immuno-Oncology International
Cancer Conference (BGICC) consensus and recommendations.
Cancer. 2024 Jul 10. doi: 10.1002/cncr.35389.
Cancer Lett
- ZHANG H, Zhang L, He Y, Jiang D, et al
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive
breast cancer.
Cancer Lett. 2024 Jul 8:217112. doi: 10.1016/j.canlet.2024.217112.
Cancer Res
- IRIONDO O, Mecenas D, Li Y, Chin CR, et al
Hypoxic Memory Mediates Prolonged Tumor Intrinsic Type I Interferon Suppression
to Promote Breast Cancer Progression.
Cancer Res. 2024 Jul 11. doi: 10.1158/0008-5472.CAN-23-2028.
Clin Breast Cancer
- EL KADDISSI A, Vernerey D, Falcoz A, Mansi L, et al
Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With
HER2-Negative Metastatic Breast Cancer.
Clin Breast Cancer. 2024 Jun 19:S1526-8209(24)00171.
- CHEN AX, Chen X, Li XX, Guo ZY, et al
Impacts of Tumor Stage at Diagnosis and Adjuvant Therapy on Long-Term Survival
Outcomes in Patients With Triple-Negative Breast Cancer Achieving Pathologic
Complete Response After Neoadjuvant Chemotherapy.
Clin Breast Cancer. 2024 Jun 21:S1526-8209(24)00178.
- MALKIELY G, Ashkenazi I, Malkin L, Zohar Y, et al
Intraoperative diagnosis of breast cancer metastasis in axillary lymph nodes:
Cytological Smear vs. Frozen Section.
Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00150.
- VUONG B, Jacinto AI, Chang SB, Kuehner GE, et al
Contemporary Review of the Management and Treatment of Young Breast Cancer
Patients.
Clin Breast Cancer. 2024 Jun 7:S1526-8209(24)00148.
- CASASANTA N, Patel R, Raymond S, Kier MW, et al
Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between
Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS).
Clin Breast Cancer. 2024 Jun 12:S1526-8209(24)00167.
Clin Cancer Res
- LLOMBART-CUSSAC A, Perez-Garcia J, Braso-Maristany F, Pare L, et al
HER2DX Genomic Assay in HER2-positive Early Breast Cancer Treated with
Trastuzumab and Pertuzumab: A Correlative Analysis from PHERGain Phase II Trial.
Clin Cancer Res. 2024 Jul 12. doi: 10.1158/1078-0432.CCR-24-0464.
Eur J Surg Oncol
- GILL SS, Shukla A, Namireddy SR, Moin S, et al
Exercise and recovery after surgery in patients with breast cancer: An analysis
of the literature.
Eur J Surg Oncol. 2024;50:108525.
Eur Radiol
- SARTOR H, Sturesdotter L, Larsson AM, Rosendahl AH, et al
Mammographic features differ with body composition in women with breast cancer.
Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10937.
- FALLENBERG EM
Implementing the advantages of contrast-enhanced mammography and
contrast-enhanced breast MRI in breast cancer staging.
Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10896.
Histopathology
- TOZBIKIAN G, Bui MM, Hicks DG, Jaffer S, et al
Best practices for achieving consensus in HER2-low expression in breast cancer:
current perspectives from practising pathologists.
Histopathology. 2024 Jul 8. doi: 10.1111/his.15275.
Int J Cancer
- BHIMANI J, O'Connell K, Persaud S, Blinder V, et al
Patient characteristics associated with delayed time to adjuvant chemotherapy
among women treated for stage I-IIIA breast cancer.
Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35053.
- JIANG C, Giaquinto AN, Jemal A, Sung H, et al
Trends in breast cancer incidence by estrogen receptor status in the United
States, 2004-2020.
Int J Cancer. 2024 Jul 10. doi: 10.1002/ijc.35073.
J Clin Oncol
- OKEYA A, Shimomura A, Kitagawa D, Shimizu C, et al
Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With
ESR1-Mutated Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative
Breast Cancer?
J Clin Oncol. 2024 Jul 11:JCO2400992. doi: 10.1200/JCO.24.00992.
Nat Rev Cancer
- HARRIS MA, Savas P, Virassamy B, O'Malley MMR, et al
Towards targeting the breast cancer immune microenvironment.
Nat Rev Cancer. 2024 Jul 5. doi: 10.1038/s41568-024-00714.
NPJ Breast Cancer
- HURVITZ SA, Bardia A, Punie K, Kalinsky K, et al
Author Correction: Subgroup analyses from the phase 3 ASCENT study of sacituzumab
govitecan in metastatic triple-negative breast cancer.
NPJ Breast Cancer. 2024;10:55.
- RONCHI C, Haider S, Brisken C
EMBER creates a unified space for independent breast cancer transcriptomic
datasets enabling precision oncology.
NPJ Breast Cancer. 2024;10:56.
Oncogene
- HAN X, Ren C, Lu C, Jiang A, et al
Phosphorylation of USP27X by PIM2 promotes glycolysis and breast cancer
progression via deubiquitylation of MYC.
Oncogene. 2024 Jul 5. doi: 10.1038/s41388-024-03097.
Pathology
- LASHEN AG, Almalki N, Toss M, Mirza S, et al
The characteristics and prognostic significance of histone H1 expression in
breast cancer.
Pathology. 2024 Jun 8:S0031-3025(24)00143-0. doi: 10.1016/j.pathol.2024.
PLoS Comput Biol
- PERRONE MC, Lerner MG, Dunworth M, Ewald AJ, et al
Prioritizing drug targets by perturbing biological network response functions.
PLoS Comput Biol. 2024;20:e1012195.
PLoS One
- AHMAD J, Akram S, Jaffar A, Ali Z, et al
Deep learning empowered breast cancer diagnosis: Advancements in detection and
classification.
PLoS One. 2024;19:e0304757.
- LI X, Niu C, Yi G, Zhang Y, et al
Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6
inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2
axis.
PLoS One. 2024;19:e0305612.
Radiol Imaging Cancer
- RESCH D, Lo Gullo R, Teuwen J, Semturs F, et al
AI-enhanced Mammography With Digital Breast Tomosynthesis for Breast Cancer
Detection: Clinical Value and Comparison With Human Performance.
Radiol Imaging Cancer. 2024;6:e230149.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016